Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Avenue Therapeutics, Inc. (ATXI) had Operating Cash Flow per Share of $-0.59 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.40M |
|
$-2.91M |
|
-- |
|
$1.40M |
|
$4.49M |
|
$-3.08M |
|
$0.14M |
|
$-2.95M |
|
$-2.95M |
|
$-2.95M |
|
$-2.95M |
|
$-2.95M |
|
$-2.95M |
|
$-3.08M |
|
$-3.08M |
|
3.13M |
|
3.13M |
|
$-0.93 |
|
$-0.93 |
|
| Balance Sheet Financials | |
$2.93M |
|
-- |
|
-- |
|
$2.93M |
|
$1.10M |
|
-- |
|
-- |
|
$1.10M |
|
$1.83M |
|
$1.83M |
|
$1.83M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-1.83M |
|
-- |
|
$2.09M |
|
$2.59M |
|
$2.85M |
|
$0.26M |
|
$0.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-219.59% |
|
-219.59% |
|
-219.59% |
|
-209.90% |
|
-207.19% |
|
$-1.83M |
|
-- |
|
-- |
|
-- |
|
0.48 |
|
-- |
|
-- |
|
-- |
|
-160.86% |
|
-160.86% |
|
-100.55% |
|
-160.86% |
|
$0.58 |
|
$-0.59 |
|
|
Operating Cash Flow per Share |
$-0.59 |